Related Experiment Video
Updated: Feb 3, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Vaccinations for Anal Squamous Cancer: Current and Emerging Therapies
1Division of Colon and Rectal Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
Abstract:
Human papillomavirus (HPV) infection is responsible for 4.3% of the global cancer burden. Since 2006, current HPV vaccines have reduced the prevalence of the virus in adolescent girls, reduced the prevalence of genital warts, and been proven to reduce the progression of anal intraepithelial neoplasia in men. Herein, we review the epidemiology, virology, and immunology behind the prophylactic HPV vaccines and current recommendations for its use. We also review future immune therapies being trialed for use against HPV-related cancers including anal cancer.
Insights
Human papillomavirus (HPV) vaccines have significantly lowered HPV prevalence and genital warts in young women. These vaccines also show promise in reducing anal intraepithelial neoplasia progression in men.
Area of Science:
- Oncology
- Immunology
- Virology
Background:
- Human papillomavirus (HPV) causes 4.3% of the global cancer burden.
- HPV infection is a significant public health concern, particularly regarding cervical and other cancers.
- Prophylactic HPV vaccines have been available since 2006.
Purpose of the Study:
- To review the epidemiology, virology, and immunology of prophylactic HPV vaccines.
- To discuss current recommendations for HPV vaccine use.
- To explore emerging immune therapies for HPV-related cancers.
Main Methods:
- Literature review of epidemiological data.
- Analysis of virological and immunological studies on HPV vaccines.
- Review of clinical trial data for HPV therapies.
Main Results:
- HPV vaccines have reduced HPV prevalence in adolescent girls.
- Vaccination has led to decreased rates of genital warts.
- Evidence shows reduced progression of anal intraepithelial neoplasia in men.
Conclusions:
- Prophylactic HPV vaccines are effective in reducing HPV infection and related conditions.
- Ongoing research is exploring advanced immune therapies for HPV-driven malignancies.
- Vaccination remains a critical strategy in HPV cancer prevention.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Emerging Adulthood
Psychosexual Stages of Personality: Anal

